Literatur
-
1
Anonymous.
Getting
evidence into practice.
Effective Health Care.
1999;
5
1
-
2
Anonymous.
Das
Leitlinien-Manual von AWMF und ÄZQ.
Z Ärztl Fortbild
Qualitätssich.
2001;
95
1-84
(Suppl 1)
-
3
Archibald L K, Gaynes R P.
Hospital-acquired
infections in the United States. The importance of interhospital
comparisons.
Infect Dis Clin North Am.
1997;
11
245-255
-
4 Archibald L K, Edwards J R, Mathema B B. et al .Imipenem-Resistant Pseudomonas aeruginosa
in selected intensive care units in the United States. ICAAC
Toronto, September 28th-October1st 1997: Abstr. J206
-
5
Baum G, Tuschen K H.
AR
DRG - Die Chancen nutzen. Überlegungen zu den
ordnungspolitischen Rahmenbedingungen des neuen DRG Entgeltsystems.
Führen
und Wirtschaften.
2000;
17
449-460
-
6 Bundesärztekammer,
Kassenärztliche Bundesvereinigung, Arbeitsgemeinschaft
der Wissenschaftlichen Medizinischen Fachgesellschaften .Curriculum
Qualitätssicherung/Ärztliches Qualitätsmanagement. 2. überarb.
Aufl., Köln 2000
-
7
Chaix C, Durand-Zaleski I, Alberti C. et al .
Control
of endemic methicillin-resistant Staphylococcus aureus. A cost-benefit
analysis in an intensive care unit.
JAMA.
1999;
282
1745-1751
-
8
Clancy C M.
Ensuring
health care quality: an AHCPR perspective. Agency for health care
policy and research.
Clin Ther.
1997;
19
1564-1571
-
9
Classen D C, Evans R S, Pestotnik S L. et al .
The timing of prophylactic administration
of antibiotics and the risk of surgical-wound infection.
N
Engl J Med.
1992;
326
281-286
-
10
Classen D C, Burke J P, Wenzel R P.
Infectious
diseases consultation: impact on outcomes for hospitalized patients
and results of a preliminary study.
Clin Infect Dis.
1997;
24
468-470
-
11
Coleman R W, Rodondi L C, Kaubisch S. et al .
Cost-effectiveness of prospective and continuous
parenteral antibiotic control: experience at the Palo Alto Veterans
Affairs Medical Center from 1987 to 1989.
Am J Med.
1991;
90
439-444
-
12
Conen D.
Behandlungspfade
als Basis für TQM und Kostenermittlung. Modell integrierter
Patientenpfade »mipp«.
Qualitätsmanagement
in Klinik und Praxis.
2000;
8
185-190
-
13
Evans M E, Millheim E T, Rapp R P.
Vancomycin
use in a University Medical Center: effect of a vancomycin continuation
form.
Infect Control Hosp Epidemiol.
1999;
20
417-420
-
14
Evans R S, Pestotnik S L, Classen D C. et al .
A computer-assisted management program
for antibiotics and other antiinfective agents.
N Engl
J Med.
1998;
338
232-238
-
15
Frank M O, Batteiger B E, Sorensen S J. et al .
Decrease in expenditures and selected nosocomial
infections following implementation of an antimicrobial-prescribing
improvement program.
Clin Perform Qual Health Care.
1997;
5
180-188
-
16
Fraser G L, Stogsdill P, Dickens J D. et al .
Antibiotic optimization. An evaluation
of patient safety and economic outcomes.
Arch Intern Med.
1997;
157
1689-1694
-
17
Gastmeier P, Sohr D, Geffers C. et al .
Are nosocomial infection rates in intensive
care units useful benchmark parameters?.
Infection.
2000;
28
346-350
-
18
Gaynes R P, Solomon S.
Improving hospital-acquired
infection rates: the CDC experience.
Jt Comm J Qual Improv.
1996;
22
457-467
-
19 Graebig K. (Hrsg.) .Qualitätsmanagement Statistik
Umweltmanagement, Anwendungshilfen und Normensammlungen. Hrsg. Deutsches
Institut für Normung e. V., Beuth Verlag, 4. Ergänzungslieferung Oktober
1996
-
20
Grol R, Dalhuijsen J, Thomas S. et al .
Attributes
of clinical guidelines that influence use of guidelines in general
practice: observational study.
BMJ.
1998;
317
858-861
-
21
Gross P A, Barrett T L, Dellinger E P. et al .
Quality standard for the treatment of bacteremia.
Infectious Diseases Society of America.
Clin Infect Dis.
1994;
18
428-430
-
22
Gums J G, Yancey R W, Hamilton C A. et al .
A randomized, prospective study measuring
outcomes after antibiotic therapy intervention by a multidisciplinary
consult team.
Pharmacotherapy.
1999;
19
1369-1377
-
23
Haley R W, White J W, Culver D H. et al .
The financial incentive for hospitals to
prevent nosocomial infections under the prospective payment system.
An empiric determination from a nationally representative sample.
JAMA.
1987;
257
1611-1614
-
24
Hauer T, Lacour M, Gastmeier P. et al .
Nosokomiale
Infektionen in Deutschland (NIDEP): Mikrobiologische Diagnostik,
Antibiotikaprophylaxe und Antibiotikatherapie.
Med Klin.
1996;
91
681-686
-
25
Jarvis W R, Edwards J R, Culver D H. et al .
Nosocomial infection rates in adult and
pediatric intensive care units in the United States. National Nosocomial
Infections Surveillance System.
Am J Med.
1991;
91
185S-191S
-
26
Jarvis W R.
Selected
aspects of the socioeconomic impact of nosocomial infections: morbidity,
mortality, cost, and prevention.
Infect Control Hosp Epidemiol.
1996;
17
552-557
-
27
John J F, Fishman N O.
Programmatic
role of the infectious diseases physician in controlling antimicrobial
costs in the hospital.
Clin Infect Dis.
1997;
24
471-485
-
28
Kollef M H.
Inadequate
antimicrobial treatment: an important determinant of outcome for
hospitalized patients.
Clin Inf Dis.
2000;
31
S131-138
(Suppl 4)
-
29
Kresken M, Hafner D.
Resistenzsituation bei
klinisch wichtigen Infektionserregern gegenüber Chemotherapeutika
in Mitteleuropa.
Chemotherapie Journal.
2000;
9
51-86
-
30
LaForce F.
US
preventive services task force: immunizations, immunoprophylaxis,
and chemoprophylaxis to prevent selected infections.
JAMA.
1997;
257
2464-2470
-
31
Leape L L, Brennan T A, Laird N. et al .
The nature of adverse events in hospitalized
patients. Results of the Harvard Medical Practice Study II.
N
Engl J Med.
1991;
324
377-384
-
32 Leitlinien-Konferenz der Kölner
Universitätsklinik,. http://www.medizin.uni-koeln.de Codewörter
können per E-mail erfragt werden
-
33
Lesar T S, Briceland L, Stein D S.
Factors
related to errors in medication prescribing.
JAMA.
1997;
277
312-317
-
34
Mehta R H, Das S, Tsai T T. et al .
Quality improvement initiative and its
impact on the management of patients with acute myocardial infarction.
Arch
Intern Med.
2000;
160
3057-3062
-
35
Metersky M L, Tate J P, Fine M J. et al .
Temporal trends in outcome of older patients
with pneumonia.
Arch Intern Med.
2000;
160
3385-3391
-
36
Morris A H.
Developing
and implementing computerized protocols for standardization of clinical
decisions.
Ann Intern Med.
2000;
132
373-383
-
37
Pestotnik S L, Classen D C, Evans R S. et al .
Implementing antibiotic practice guidelines
through computer-assisted decision support: clinical and financial
outcomes.
Ann Intern Med.
1996;
1124
884-890
-
38
Reacher M H, Shah A, Livermore D M. et al .
Bacteriaemia and antibiotic resistance
of its pathogens reported in England and Wales between 1990 and
1998: trend analysis.
Brit Med J.
2000;
320
213-216
-
39
Richards M J, Edwards J R, Culver D H. et al .
Nosocomial infections in coronary care
units in the United States. National Nosocomial Infections Surveillance
System.
Am J Cardiol.
1998;
82
789-793
-
40
Rogers R WH, Draper D, Kahn K L. et al .
Quality of care before and after implementation
of the DRG-based prospective payment system: a summary of effects.
JAMA.
1990;
264
1989-1994
-
41 Scheinert H -D, Kolkmann F -W, Walger M. KTQR-Manual
inkl. KTQR-Katalog Version 3.0 für den Einsatz in der Pilotphase. Deutsche
Krankenhaus-Verlagsgesellschaft, Düsseldorf 2000
-
42
Schlesinger Y, Paltiel O, Yinnon A M.
Analysis
and impact of infectious disease consultations in a general hospital.
J
Hosp Infect.
1998;
40
39-46
-
43
Schrappe M, Seifert H, Theisohn M.
Antibiotikapolitik
im Krankenhaus: restriktiv oder liberal?.
Hygiene und Mikrobiologie.
1998;
2
37-42
-
44
Schrappe M, Bollschweiler E, Grüne F. et al .
The Cologne guideline committee: computer-assisted
clinical practice guidelines on clinical diagnosis.
Z
Arztl Fortbild Qualitatssich.
1999;
93
447-453
-
45
Shiffman R N, Liaw Y, Brandt C A. et al .
Computer-based guideline implementation
systems: a systematic review of functionality and effectiveness.
J
Am Med Inform Assoc.
1999;
6
104-114
-
46 Spemann T F, Wandschneider U, Rösener C. et al .Krankenhaus 2015. Wege aus dem Paragraphendschungel. Arthur
Andersen, Health Care 2000
-
47 Ulsenheimer K. Medikolegale
Aspekte der Leitlinien-Erstellung: nationale und interne Leitlinien.
Vortrag auf dem 1. Leitlinien-Workshop, Köln, 29.-30.10.1999. Stuttgart,
Schattauer Siehe auch K. Ulsenheimer: Risk-Management,
in: K. Lauterbach, M. Schrappe (Hrsg.): Gesundheitsökonomie,
Qualitätsmanagement und Evidence based Medicine 2001: 333-338
-
48
White R L, Friedrich L V, Mihm L B. et al .
Assessment of the relationship between
antimicrobial usage and susceptibility: differences between the
hospital and specific patient-care areas.
Clin Inf Dis.
2000;
31
16-23
-
49
Wolters U, Schrappe M, Möhrs D. et al .
Bewirken Leitlinien eine Verbesserung des
perioperativen Ablaufs? Untersuchung anhand der perioperativen Antibiotikaprophylaxe.
Chirurg.
2000;
71
702-707
-
50
Zielstorff R D.
Online
practice guidelines: issues, obstacles, and future prospects.
J
Am Med Inform Assoc.
1998;
5
227-236
Korrespondenz
Prof. Dr. med. Matthias Schrappe
Klinikum der Philipps-Universität Marburg/L.
Baldinger Straße
35043 Marburg
Phone: 06421/2866100
Fax: 06421/2866102
Email: Schrappe@med.uni-marburg.de
